Answers are grounded in this paper and cite their sources.
A new asymmetric ligand, 5-{3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl}-2-(pyridin-3-yl)-1,3,4-oxadiazole (L5), which contains two oxadiazole rings, was synthesized and characterized. The assembly of symmetric 2,5-bis(pyridin-3-yl)-1,3,4-oxadiazole (L1) and asymmetricL5with AgCO2CF3in solution yielded two novel AgIcomplexes, namelycatena-poly[[di-μ-trifluoroacetato-disilver(I)]-bis[μ-2,5-bis(pyridin-3-yl)-1,3,4-oxadiazole]], [Ag2(C2F3O2)2(C12H8N4O)2]nor [Ag2(μ2-O2CCF3)2(L1)2]n(1), and bis(μ3-5-{3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl}-2-(pyridin-3-yl)-1,3,4-oxadiazole)tetra-μ3-trifluoroacetato-tetrasilver(I) dichloromethane monosolvate, [Ag4(C2F3O2)4(C22H15N5O2)2]·CH2Cl2or [Ag2(μ3-O2CCF3)2(L5)]2·CH2Cl2(2). Complex1displays a one-dimensional ring–chain motif, where dinuclear Ag2(CF3CO2)2units alternate with Ag2(L1)2macrocycles. This structure is different from previously reported Ag–L1complexes with different anions. Complex2features a tetranuclear supramolecular macrocycle, in which each ligand adopts a tridentate coordination mode with the oxadiazole ring next to thep-tolyl ring coordinated and that next to the pyridyl ring free. TwoL5ligands are bound to two Ag1 centres through two oxadiazole N and two pyridyl N atoms to form a macrocycle. The other two oxadiazole N atoms coordinate to the two Ag2 centres of the Ag2(O2CCF3)4dimer. Each CF3CO2−anion adopts a μ3-coordination mode, bridging the Ag1 and Ag2 centres to form a tetranuclear silver(I) complex. This study indicates that the donor ability of the bridging oxadiazole rings can be tuned by electron-withdrawing and -donating substituents. The emission properties of ligandsL1andL5and complexes1and2were also investigated in the solid state.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: